Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|February 24, 1997
Phalangeal bone density and hip fracture riskM E Mussolino, A C Looker, J H Madans, et al.
Antimicrobial Agents and Chemotherapy|September 3, 1999
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patientsS C Piscitelli, K Spooner, B Baird, et al.
Bone|October 13, 2015
Osteolytica: An automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methodsH R Evans, T Karmakharm, M A Lawson, et al.
European Journal of Clinical Nutrition|November 26, 2015
Intermittent energy restriction and weight loss: a systematic reviewC S Davis, R E Clarke, S N Coulter, et al.
Annals of Internal Medicine|March 1, 1988
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudineR E Walker, R I Parker, J A Kovacs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twinsN Rebai, G Pantaleo, J F Demarest, et al.
Annals of Internal Medicine|July 1, 1989
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trialH C Lane, J Falloon, R E Walker, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661R T Davey, R L Dewar, G F Reed, et al.
The New England Journal of Medicine|March 2, 1995
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary studyJ A Kovacs, M Baseler, R J Dewar, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruriaM A Polis, K M Spooner, B F Baird, et al.
Pageof 6